Your browser doesn't support javascript.
loading
Reinfection following successful direct-acting antiviral therapy for HCV infection among people attending an inner-city community health centre in Victoria, Canada.
Selfridge, Marion; Cunningham, Evan B; Barnett, Tamara; Drost, Anne; Gray-Schleihauf, Christianne; Guarasci, Kellie; Lundgren, Karen; Milne, Roz; Grebely, Jason; Fraser, Chris.
Affiliation
  • Selfridge M; Cool Aid Community Health Centre, Victoria, Canada. Electronic address: marions@uvic.ca.
  • Cunningham EB; The Kirby Institute, UNSW Sydney, Sydney, Australia.
  • Barnett T; Cool Aid Community Health Centre, Victoria, Canada.
  • Drost A; Cool Aid Community Health Centre, Victoria, Canada.
  • Gray-Schleihauf C; Cool Aid Community Health Centre, Victoria, Canada.
  • Guarasci K; Cool Aid Community Health Centre, Victoria, Canada.
  • Lundgren K; Cool Aid Community Health Centre, Victoria, Canada.
  • Milne R; Cool Aid Community Health Centre, Victoria, Canada.
  • Grebely J; The Kirby Institute, UNSW Sydney, Sydney, Australia.
  • Fraser C; Cool Aid Community Health Centre, Victoria, Canada.
Int J Drug Policy ; 96: 103418, 2021 10.
Article in En | MEDLINE | ID: mdl-34538704
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Substance Abuse, Intravenous / Hepatitis C / Hepatitis C, Chronic Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Female / Humans Country/Region as subject: America do norte Language: En Journal: Int J Drug Policy Year: 2021 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Substance Abuse, Intravenous / Hepatitis C / Hepatitis C, Chronic Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Female / Humans Country/Region as subject: America do norte Language: En Journal: Int J Drug Policy Year: 2021 Document type: Article